| ONCT Stock | | | USD 0.71 0.43 37.72% |
Oncternal Therapeutics financial indicator trend analysis is much more than just breaking down Oncternal Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Oncternal Therapeutics is a good investment. Please check the relationship between Oncternal Therapeutics Total Operating Expenses and its Ebitda accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncternal Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in main economic indicators.
For more information on how to buy Oncternal Stock please use our
How to Invest in Oncternal Therapeutics guide.
Total Operating Expenses vs Ebitda
Total Operating Expenses vs Ebitda Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Oncternal Therapeutics Total Operating Expenses account and
Ebitda. At this time, the significance of the direction appears to have pay attention.
The correlation between Oncternal Therapeutics' Total Operating Expenses and Ebitda is -0.92. Overlapping area represents the amount of variation of Total Operating Expenses that can explain the historical movement of Ebitda in the same time period over historical financial statements of Oncternal Therapeutics, assuming nothing else is changed. The correlation between historical values of Oncternal Therapeutics' Total Operating Expenses and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Operating Expenses of Oncternal Therapeutics are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Total Operating Expenses i.e., Oncternal Therapeutics' Total Operating Expenses and Ebitda go up and down completely randomly.
Correlation Coefficient | -0.92 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Ebitda
Most indicators from Oncternal Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Oncternal Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncternal Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in main economic indicators.
For more information on how to buy Oncternal Stock please use our
How to Invest in Oncternal Therapeutics guide.At this time, Oncternal Therapeutics'
Sales General And Administrative To Revenue is comparatively stable compared to the past year.
Enterprise Value Over EBITDA is likely to gain to 11.81 in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 3.1
M in 2024.
Oncternal Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Oncternal Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Oncternal Therapeutics fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Oncternal Stock Analysis
When running Oncternal Therapeutics' price analysis, check to
measure Oncternal Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncternal Therapeutics is operating at the current time. Most of Oncternal Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Oncternal Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncternal Therapeutics' price. Additionally, you may evaluate how the addition of Oncternal Therapeutics to your portfolios can decrease your overall portfolio volatility.